In:
Reviews in the Neurosciences, Walter de Gruyter GmbH, Vol. 30, No. 7 ( 2019-10-25), p. 757-770
Abstract:
Type 2 diabetes mellitus (T2DM) is becoming a significant health issue worldwide. Many studies support the hypothesis that patients with T2DM have a higher-than-expected incidence of mild cognitive impairment (MCI) than individuals without diabetes. Based on the results from recent studies, MCI might be associated with the effects of T2DM on glucose metabolism and brain atrophy. As a narrative review, we will illuminate pathological and cognitive changes in patients with T2DM and comorbid MCI and protective hypoglycemic therapies. The early abnormal signs of cognition must be elucidated, and extensive investigations are needed to develop improved therapies for use in the clinic.
Type of Medium:
Online Resource
ISSN:
2191-0200
,
0334-1763
DOI:
10.1515/revneuro-2018-0083
Language:
English
Publisher:
Walter de Gruyter GmbH
Publication Date:
2019
detail.hit.zdb_id:
2598365-9
Permalink